These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1306883)
1. Introduction of erythropoietin in the treatment of acute lymphoblastic leukemia (ALL) in a patient of Jehovah's Witnesses persuasion: a case report. Blütters-Sawatzki R; Bertram U Med Pediatr Oncol Suppl; 1992; 2():23-5. PubMed ID: 1306883 [No Abstract] [Full Text] [Related]
2. [Acute leukemia in Jehovah's Witnesses: difficulties in its management]. Gómez-Almaguer D; Ruiz-Argüelles G; Lozano de la Vega A; García-Guajardo BM Rev Invest Clin; 1990; 42(4):317-20. PubMed ID: 2091183 [TBL] [Abstract][Full Text] [Related]
4. [The problem of blood transfusion ++ in Jehova's Witnesses' children with oncological disease]. Kałmuk A; Sońta-Jakimczyk D; Janik-Moszant A; Bubała H; Olejnik I Wiad Lek; 1998; 51 Suppl 4():346-50. PubMed ID: 10731998 [TBL] [Abstract][Full Text] [Related]
5. Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemia. Kerridge I; Lowe M; Seldon M; Enno A; Deveridge S Arch Intern Med; 1997 Aug 11-25; 157(15):1753-7. PubMed ID: 9250237 [TBL] [Abstract][Full Text] [Related]
10. The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapy. Johnson PW; King R; Slevin ML; White H Br J Cancer; 1991 Mar; 63(3):476. PubMed ID: 2003993 [No Abstract] [Full Text] [Related]
11. Successful treatment for acute lymphoblastic leukemia without blood transfusion in a Jehovah's Witness. Takeuchi S; Utsunomiya A; Makino T; Shimotakahara S; Takatsuka Y; Kawabata H; Nakashima A Am J Hematol; 1999 Feb; 60(2):168-9. PubMed ID: 9929116 [No Abstract] [Full Text] [Related]
12. Successful treatment of acute promyelocytic leukemia using all-trans retinoic acid and erythropoietin in a Jehovah's Witness boy. Menéndez A; Svarch E; Martínez G; Hernández P Ann Hematol; 1998 Jan; 76(1):43-4. PubMed ID: 9486924 [TBL] [Abstract][Full Text] [Related]
14. The use of erythropoietin in two burned patients who are Jehovah's Witnesses. Law EJ; Still JM; Gattis CS Burns; 1991 Feb; 17(1):75-7. PubMed ID: 2031685 [TBL] [Abstract][Full Text] [Related]
15. Jehovah's Witnesses: unique problems in a unique trauma population. Victorino G; Wisner DH J Am Coll Surg; 1997 May; 184(5):458-68. PubMed ID: 9145065 [TBL] [Abstract][Full Text] [Related]
16. Use of recombinant human erythropoietin (r-HuEPO) in a Jehovah's Witness refusing transfusion of blood products: case report. Koestner JA; Nelson LD; Morris JA; Safcsak K J Trauma; 1990 Nov; 30(11):1406-8. PubMed ID: 2231810 [TBL] [Abstract][Full Text] [Related]
17. Use of erythropoietin in Jehovah's Witness children following acute gastrointestinal blood loss. Smith SN; Milov DE J Fla Med Assoc; 1993 Feb; 80(2):103-5. PubMed ID: 8455008 [TBL] [Abstract][Full Text] [Related]
18. Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. Chojnowski K; Janus A; Bliźniewska K; Robak M; Treliński J Transfusion; 2016 Oct; 56(10):2438-2442. PubMed ID: 27385671 [TBL] [Abstract][Full Text] [Related]